PHI with Diffuse periaxial encephalitis

How does this condition affect your private health insurance?

Encephalitis periaxialis diffusa, also known as Schilder's disease, is a rare demyelinating disorder primarily affecting the brain's white matter. It is characterized by large, bilateral, and confluent demyelinating lesions. Often considered a variant of multiple sclerosis (MS) or acute disseminated encephalomyelitis (ADEM), it causes progressive neurological deficits such as visual impairment, seizures, motor weakness, and cognitive decline. The disease course varies, presenting as monophasic, relapsing, or progressively worsening. Diagnosis relies on clinical presentation, MRI findings, and exclusion of other conditions. Treatment focuses on reducing inflammation and managing symptoms, often with corticosteroids, but prognosis can be severe.

PKV Risk Assessment

Very High Risk of Rejection

Individual, specialized PHI providers may still insure you, but with a significant surcharge.

Impact on Your Insurance Policy

Duration of Illness (Initial)

Weeks to months (acute to subacute onset)

Duration of Illness (Lifetime)

Chronic, often progressive or relapsing-remitting, leading to long-term disability

Cost of Treatment (Initial)

Tens of thousands to hundreds of thousands of USD (due to hospitalization, diagnostics, and acute treatments)

Cost of Treatment (Lifetime)

Hundreds of thousands to millions of USD (due to chronic management, rehabilitation, long-term care, and medications)

Mortality Rate

Moderate to high (10-50%), especially in severe or rapidly progressive forms

Risk of Secondary Damages

Very high (>80%) for significant physical (e.g., motor deficits, visual impairment), cognitive (e.g., dementia), and psychological sequelae

Probability of Full Recovery

Low (<10%), complete recovery without any lasting neurological consequences is rare

Underlying Disease Risk

Low (<5%), as Schilder's disease is typically a primary demyelinating disorder and not strongly associated with other specific underlying diseases, although it can be a phenotype of MS or ADEM.

The information provided is for general informational purposes only and is not a substitute for professional medical or insurance advice. Always consult with a qualified professional for any health concerns or before making any insurance decisions.